HKGEquity · Weekly research terminal

6915

JIANGXI BIO

HK Healthcare Drug Manufacturers - General

Latest week
7 Aug 2026
Weekly close
9.63 HKD
Fair value
9.23 HKD
Next-week expectancy
Positive 78.22%
SM Sharemaestro
Institutional Weekly Chart Pack Completed-week market evidence · Maximum 156 weeks

HKG · Equity · Hong Kong

6915

JIANGXI BIO

Healthcare Drug Manufacturers - General

Jiangxi Institute of Biological Products Inc. manufactures and exports biological products including Tetanus Antitoxin and Veterinary Medicine. The company offers Antitoxin Formulations, Active Pharmaceutical Ingredients, Equine Byproducts, essential oils, and plant extracts. It serves businesses in China and international markets. The company was founded in 1969 and is based in Ji'an, China. Jiangxi Institute of Biological Products Inc. is a subsidiary of Shenzhen Qianhai Tianzheng Biotechnology Co., Ltd.

Last updated
7 Aug 2026
Exchange
Hong Kong Stock Exchange · HKG
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
HKD
Market capitalisation
3,950,313,472
Fair value reference
9.23
Next-week expectancy
Positive · 78.22%

Over the latest 12 completed weeks ending 2026-08-07, 6915 rose 51.18%, moving from 6.37 to 9.63. The latest weekly close is above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 6 weeks. Market Dynamics is 0.00 on the latest week. Next-week expectancy is positive at 78.22% based on similar historical setup states.

Week Ending
7 Aug 2026
Latest Close
9.63
12-Week Change
51.18%
Trend Signal
Inactive
Next-Week Expectancy
Positive 78.22%
Signal Weeks
0 of 6

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
7 Aug 2026
Latest Close
9.63
12-Week Change
51.18%
Trend Signal
Inactive
Next-Week Expectancy
Positive 78.22%
Signal Weeks
0 of 6
Vs Fair Value
Above
Market Dynamics
0.00

Over the latest 12 completed weeks ending 2026-08-07, 6915 rose 51.18%, moving from 6.37 to 9.63. The latest weekly close is above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 6 weeks. Market Dynamics is 0.00 on the latest week. Next-week expectancy is positive at 78.22% based on similar historical setup states.

Industry Peers

Hong Kong equities in Drug Manufacturers - General

Stock Exchange Week Open High Low Close Change
2630 Vigonvita Life Sciences Co., Ltd. HKG 7 Aug 2026 96.00 118.80 91.30 116.80 21.67%
9637 Alebund Pharmaceuticals (Jiangsu) Limited HKG 7 Aug 2026 27.74 33.80 27.74 32.68 17.81%
1093 CSPC Pharmaceutical Group Limited HKG 7 Aug 2026 8.52 8.76 8.21 8.69 2.00%
1666 Tong Ren Tang Technologies Co. Ltd. HKG 7 Aug 2026 3.50 3.57 3.31 3.37 -3.86%
7630 IMPACT THERAP-B HKG 7 Aug 2026 13.23 13.23 11.42 12.51 -5.44%
1643 Modern Chinese Medicine Group Co., Ltd. HKG 7 Aug 2026 1.10 1.10 0.85 0.85 -23.18%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.

Evidence context